Due to a tight interconnection between BRCA1 and epigenetic mechanisms, BRCA1-deficient breast cancer cells are less sensitive to epigenetic inhibition, such as treatment with the HDAC inhibitor SAHA [205]. Here, BRCA1 is linked to breast carcinoma.